Currently approved only for NJ and NY The Exalenz BreathID® lab assay is indicated for use as an aid in the initial diagnosis and post treatment monitoring of H. pylori infection in adult patients. It is intended for use to non-invasively measure changes in the 13CO2/12CO2 ratio of exhaled breath, which may be indicative of increased urease production associated with active Helicobacter pylori (H. pylori) infection in the stomach.

The Exalenz BreathID® lab assay is indicated for use as an aid in the initial diagnosis and post treatment monitoring of H. pylori infection in adult patients. It is intended for use to non-invasively measure changes in the 13CO2/12CO2 ratio of exhaled breath, which may be indicative of increased urease production associated with active Helicobacter pylori (H. pylori) infection in the stomach.